The Evolving Role of Genotypic Data

Ruben A. Mesa, MD

Video Categories: Myelofibrosis

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.

Related Videos

July 25, 2018

New Clinical Trial Data Presented at ASCO 2018: How Will it Change How you Practice?

Dr David Spigel discusses the 2 major themes highlighted at ASCO 2018: the use of cancer biomarkers to achieve precision therapy, and fine tuning treatment of patients with immunotherapy with respect to who to treat, how to treat, and how to predict clinical outcomes.

September 2, 2015

Challenges with Oral Oncolytics for Healthcare Practitioners

As more oral oncolytics are developed, choosing the right regimen for prolonged disease-free survival presents a major patient management challenge. Dixie-Lee Esseltine, MD and George Mulligan, PhD explain that healthcare practitioners will have to make informed choices by balancing information emerging across similar trials.